An Extract from Shrimp Processing By-Products Protects SH-SY5Y Cells from Neurotoxicity Induced by Aβ25-35

Mar Drugs. 2017 Mar 22;15(3):83. doi: 10.3390/md15030083.

Abstract

Increased evidence suggests that marine unsaturated fatty acids (FAs) can protect neurons from amyloid-β (Aβ)-induced neurodegeneration. Nuclear magnetic resonance (NMR), high performance liquid chromatography (HPLC) and gas chromatography (GC) assays showed that the acetone extract 4-2A obtained from shrimp Pandalus borealis industry processing wastes contained 67.19% monounsaturated FAs and 16.84% polyunsaturated FAs. The present study evaluated the anti-oxidative and anti-inflammatory effects of 4-2A in Aβ25-35-insulted differentiated SH-SY5Y cells. Cell viability and cytotoxicity were measured by using 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and lactate dehydrogenase (LDH) assays. Quantitative PCR and Western blotting were used to study the expression of neurotrophins, pro-inflammatory cytokines and apoptosis-related genes. Administration of 20 μM Aβ25-35 significantly reduced SH-SY5Y cell viability, the expression of nerve growth factor (NGF) and its tyrosine kinase TrkA receptor, as well as the level of glutathione, while increased reactive oxygen species (ROS), nitric oxide, tumor necrosis factor (TNF)-α, brain derived neurotrophic factor (BDNF) and its TrkB receptor. Aβ25-35 also increased the Bax/Bcl-2 ratio and Caspase-3 expression. Treatment with 4-2A significantly attenuated the Aβ25-35-induced changes in cell viability, ROS, GSH, NGF, TrkA, TNF-α, the Bax/Bcl-2 ratio and Caspase-3, except for nitric oxide, BDNF and TrKB. In conclusion, 4-2A effectively protected SH-SY5Y cells against Aβ-induced neuronal apoptosis/death by suppressing inflammation and oxidative stress and up-regulating NGF and TrKA expression.

Keywords: Acetone extract from shrimp processing by-product (4-2A); Alzheimer’s disease (AD); Aβ25–35; human neuroblastoma cell (SH-SY5Y); neuroprotection; polyunsaturated fatty acids.

MeSH terms

  • Amyloid beta-Peptides / adverse effects*
  • Amyloid beta-Peptides / metabolism*
  • Animals
  • Apoptosis / drug effects
  • Brain-Derived Neurotrophic Factor / metabolism
  • Caspase 3 / metabolism
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Crustacea / chemistry*
  • Cytoprotection / drug effects
  • Humans
  • Neuroblastoma / drug therapy
  • Neurons / drug effects*
  • Neurons / metabolism
  • Neuroprotective Agents / chemistry*
  • Neuroprotective Agents / pharmacology*
  • Neurotoxicity Syndromes / drug therapy*
  • Neurotoxicity Syndromes / metabolism
  • Oxidative Stress / drug effects
  • Peptide Fragments / adverse effects*
  • Peptide Fragments / metabolism*
  • Reactive Oxygen Species / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Amyloid beta-Peptides
  • Brain-Derived Neurotrophic Factor
  • Neuroprotective Agents
  • Peptide Fragments
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • amyloid beta-protein (25-35)
  • BDNF protein, human
  • Caspase 3